Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» funding
funding
TORL BioTherapeutics launches with $158M to target cancer
Labiotech.eu
Sun, 04/16/23 - 11:12 pm
TORL BioTherapeutics
cancer
funding
biologics
Aer Therapeutics Raises $36M for Novel Approach to COPD
BioSpace
Fri, 04/14/23 - 10:04 am
Aer Therapeutics
COPD
funding
Alentis Wins $105M in Series C to Advance Claudin-1-Based Therapies
BioSpace
Thu, 04/13/23 - 10:10 pm
Alentis
funding
claudin-1
tight junction proteins
Function Oncology raises $28M to use CRISPR to tailor cancer diagnosis and treatment
BioPharma Dive
Thu, 04/13/23 - 10:04 am
Function Oncology
CRISPR
diagnostics
funding
cancer
Function Oncology raises $28M to use CRISPR to tailor cancer diagnosis and treatment
Medtech Dive
Wed, 04/12/23 - 10:05 pm
Function Oncology
funding
CRISPR
diagnostics
A lean first quarter for venture-backed developers
EP Vantage
Wed, 04/5/23 - 10:02 am
funding
venture capital
ArriVent Biopharma
Flare Therapeutics GSK
Hemab
Cure Ventures unveils inaugural $350M fund with focus on diligent seed rounds to de-risk new science
Fierce Biotech
Tue, 04/4/23 - 10:21 am
Cure Ventures
biotech
funding
venture capital
With one of biotech's largest private rounds in a year, ArriVent enters PhIII
Endpoints
Mon, 03/27/23 - 11:25 am
ArriVent Biopharma
funding
solid tumors
Biotech startups face ‘Series A cliff’ as venture capital stays cautious
BioPharma Dive
Fri, 03/24/23 - 10:08 am
funding
venture capital
Series A
Series B
Neurotechnology company Cognito Therapeutics scores $73M to study Alzheimer's device
Mobihealthnews
Thu, 03/23/23 - 09:19 pm
Cognito Therapeutics
Alzheimer's disease
Medtech
funding
neuromodulation
Flare fires up with $123M series B to target transcription factors with 3 Big Pharmas in tow
Fierce Biotech
Wed, 03/22/23 - 10:13 am
Flare Therapeutics
funding
Pfizer
Eli Lilly
Novartis
transcription factors
Return of the megaround: Is biotech back from the brink?
Fierce Biotech
Tue, 03/21/23 - 10:08 am
Rapport Therapeutics
Noema Pharma
Bicara Therapeutics
funding
venture capital
Switch Therapeutics launches with $52M to capitalize on RNA medicine ‘era’
BioPharma Dive
Wed, 03/15/23 - 12:11 pm
Switch Therapeutics
RNA
funding
QurAlis’ Biomarker-Driven Approach Attracts $88M in Series B
BioSpace
Fri, 03/10/23 - 09:47 am
QurAlis
ALS
funding
biomarkers
Female-owned biotech startup, Tiamat Sciences raise an extension of $2M to accelerate product validation and strategic partnerships
BioSpace
Fri, 03/10/23 - 09:41 am
Tiamat
startups
funding
recombinant growth factors
female-owned
Armed with $60M series A and Lilly's backing, Volastra enters clinic via Amgen cancer med
Fierce Biotech
Tue, 03/7/23 - 11:45 am
Volastra Therapeutics
Eli Lilly
funding
sovilnesib
Amgen
cancer
Swiss biotech Noema raises $112m for Roche castoffs
Pharmaphorum
Tue, 03/7/23 - 11:19 am
Noema
Roche
neurological disorders
funding
Future of generative AI in pharma
Pharmaphorum
Mon, 03/6/23 - 11:55 am
artificial intelligence
generative AI
funding
US spent nearly $32B in public funds on mRNA vaccine development, study finds
Endpoints
Thu, 03/2/23 - 10:59 pm
federal government
funding
COVID-19
vaccines
TandemAI raises $35M in Series A for small molecule discovery, wet labs
Endpoints
Wed, 03/1/23 - 09:50 am
TandemAI
funding
artificial intelligence
small molecule drugs
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »